Role of nuclear factor-kappa B in melanoma von Amiri, Katayoun I, Richmond, Ann

Volltext

BMS-345541 Targets Inhibitor of κB Kinase and Induces Apoptosis in Melanoma: Involvement of Nuclear Factor κB and Mitochondria Pathways von JINMING YANG, AMIRI, Katayoun I, BURKE, James R, SCHMID, Johannes A, RICHMOND, Ann

Volltext

Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescence von Liu, Yan, Hawkins, Oriana E., Su, Yingjun, Vilgelm, Anna E., Sobolik, Tammy, Thu, Yee‐Mon, Kantrow, Sara, Splittgerber, Ryan C., Short, Sarah, Amiri, Katayoun I., Ecsedy, Jeffery A., Sosman, Jeffery A., Kelley, Mark C., Richmond, Ann

Volltext

Real-World Treatment Patterns and Outcomes Among Patients With Metastatic NSCLC Previously Treated With Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors von Bains, Savreet, Kalsekar, Anu, Amiri, Katayoun I., Weiss, Jared

Volltext

RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors von YINGJUN SU, VILGELM, Anna E, ZAJA-MILATOVIC, Snjezana, BROWN DAHLMAN, Kimberly, AMIRI, Katayoun I, AIXIANG JIANG, PENGCHENG LU, YU SHYR, STUART, Darrin D, SHAWN LEVY, SOSMAN, Jeffrey A, RICHMOND, Ann, KELLEY, Mark C, HAWKINS, Oriana E, YAN LIU, BOYD, Kelli L, KANTROW, Sara, SPLITTGERBER, Ryan C, SHORT, Sarah P, SOBOLIK, Tammy

Volltext

Hairpin DNA coated gold nanoparticles as intracellular mRNA probes for the detection of tyrosinase gene expression in melanoma cells von Harry, S Reese, Hicks, Donna J, Amiri, Katayoun I, Wright, David W

Volltext

A Phase I Trial of Bortezomib with Temozolomide in Patients with Advanced Melanoma: Toxicities, Antitumor Effects, and Modulation of Therapeutic Targets von Su, Yingjun, Amiri, Katayoun I, Horton, Linda W, Yu, Yingchun, Ayers, Gregory D, Koehler, Elizabeth, Kelley, Mark C, Puzanov, Igor, Richmond, Ann, Sosman, Jeffrey A

Volltext

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group von Ciombor, Kristen K., Feng, Yang, Benson, Al Bowen, Su, Yingjun, Horton, Linda, Short, Sarah P., Kauh, John Sae Wook, Staley, Charles, Mulcahy, Mary, Powell, Mark, Amiri, Katayoun I., Richmond, Ann, Berlin, Jordan

Volltext

P1.47: ABOUND.sqm QoL by Response: Interim Analysis of Squamous NSCLC Pts Treated With nab-Paclitaxel/Carboplatin Induction Therapy: Track: Advanced NSCLC von Langer, Corey, Hirsh, Vera, Amiri, Katayoun I., Ko, Amy, Knoble, Jeanna, Johnson, Melissa, Jotte, Robert, Mccleod, Michael, Ong, Teng Jin, Page, Ray, Spigel, David, West, Howard J., Trunova, Nataliya

Volltext

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2 von Gajra, Ajeet, Karim, Nagla Abdel, Mulford, Deborah A, Villaruz, Liza Cosca, Matrana, Marc Ryan, Ali, Haythem Y, Santos, Edgardo S, Berry, Tymara, Ong, Teng Jin, Sanford, Alexandra, Amiri, Katayoun, Spigel, David R

Volltext

PS01.08: ABOUND.PS2 Interim Safety Results: nab-Paclitaxel/Carboplatin Followed by nab-Paclitaxel in NSCLC Patients with ECOG PS of 2: Topic: Medical Oncology von Gajra, Ajeet, Ali, Haythem, Amiri, Katayoun I., Karim, Nagla A., Matrana, Marc R., Mulford, Deborah, Ong, Teng J., Sanford, Alexandra, Santos, Edgardo S., Socinski, Mark A., Spigel, David R.

Volltext

Safety and efficacy of nab -paclitaxel ( nab -P)–based therapy in patients (pts) with non-small cell lung cancer (NSCLC) and performance status (PS) 2: Results from ABOUND.PS2 von Gajra, Ajeet, Karim, Nagla Abdel, Mulford, Deborah A., Villaruz, Liza Cosca, Matrana, Marc Ryan, Ali, Haythem Y., Santos, Edgardo S., Ong, Teng Jin, Sanford, Alexandra, Amiri, Katayoun, Spigel, David R.

Volltext

ABOUND.70+: Safety and efficacy of nab -paclitaxel/carboplatin ( nab -P/C) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC) von Langer, Corey J., Anderson, Eric C., Jotte, Robert M., Goldman, Jonathan Wade, Haggstrom, Daniel Ernest, Socoteanu, Matei Paul, Smith, David A., Dakhil, Christopher, Konduri, Kartik, Kim, Edward S., Ong, Teng Jin, Sanford, Alexandra, Amiri, Katayoun, Weiss, Jared

Volltext

Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: Implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma von AMIRI, Katayoun I, HORTON, Linda W, LAFLEUR, Bonnie J, SOSMAN, Jeffrey A, RICHMOND, Ann

Volltext

Quality of life (QoL) by response: An interim analysis of patients (pts) with squamous (SCC) NSCLC treated with nab -paclitaxel/carboplatin ( nab -P/C) induction therapy in the pha... von Langer, Corey J., Hirsh, Vera, Amiri, Katayoun, Ko, Amy, Knoble, Jeanna L., Johnson, Melissa Lynne, Jotte, Robert M., McCleod, Michael, Ong, Teng Jin, Page, Ray D., Spigel, David R., West, Howard Jack

Volltext

PS01.08: ABOUND.PS2 Interim Safety Results: nab -Paclitaxel/Carboplatin Followed by  nab -Paclitaxel in NSCLC Patients with ECOG PS of 2 von Gajra, Ajeet, Ali, Haythem, Amiri, Katayoun I., Karim, Nagla A., Matrana, Marc R., Mulford, Deborah, Ong, Teng J., Sanford, Alexandra, Santos, Edgardo S., Socinski, Mark A., Spigel, David R.

Volltext

P1.47: ABOUND.sqm QoL by Response: Interim Analysis of Squamous NSCLC Pts Treated With nab-Paclitaxel/Carboplatin Induction Therapy von Langer, Corey, Hirsh, Vera, Amiri, Katayoun I., Ko, Amy, Knoble, Jeanna, Johnson, Melissa, Jotte, Robert, Mccleod, Michael, Ong, Teng Jin, Page, Ray, Spigel, David, West, Howard J., Trunova, Nataliya

Volltext

Hairpin DNA coated gold nanoparticles as intracellular mRNA probes for the detection of tyrosinase gene expression in melanoma cellsElectronic supplementary information (ESI) avail... von Harry, S. Reese, Hicks, Donna J, Amiri, Katayoun I, Wright, David W

Volltext

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC von Langer, Corey J, Kim, Edward S, Anderson, Eric C, Jotte, Robert M, Modiano, Manuel, Haggstrom, Daniel E, Socoteanu, Matei P, Smith, David A, Dakhil, Christopher, Konduri, Kartik, Berry, Tymara, Ong, Teng J, Sanford, Alexandra, Amiri, Katayoun, Goldman, Jonathan W, Weiss, Jared

Volltext

Role of nuclear factor-[alpha] B in melanoma von Amiri, Katayoun I, Richmond, Ann

Volltext